Fulgent Genetics files Form 144 for 45,304 vested shares

Fulgent Genetics filed a Form 144 notice reporting intended resale of restricted common stock that vested on 02/25/2025.

Rhea-AI Filing Summary

Fulgent Genetics filed a Form 144 notice reporting intended resale of restricted common stock that vested on 02/25/2025. The filing lists 45,304 shares linked to equity compensation and discloses a prior sale of 1,201 shares on 05/27/2026.

The notice names Jian Xie and gives broker information for Morgan Stanley Smith Barney LLC. The filing is administrative: it reports quantities and dates related to restricted stock and a recent small disposition.

Insights

Securities Compliance Analyst

Form 144 lists vested restricted shares and a recent small sale by a reporting person.

The notice records 45,304 shares described as "Restricted stock vest" with a vesting date of 02/25/2025 and shows a sale of 1,201 shares on 05/27/2026. Broker details name Morgan Stanley Smith Barney LLC.

These entries are procedural disclosures required under resale rules; cash‑flow treatment and any price per share are not provided in the excerpt. Subsequent filings would be needed for price or proceeds details.

Key Figures

Restricted shares listed: 45,304 shares Shares sold in past 3 months: 1,201 shares Broker listed: Morgan Stanley Smith Barney LLC +1 more

4 metrics

Restricted shares listed 45,304 shares Restricted stock vest dated 02/25/2025

Shares sold in past 3 months 1,201 shares Sale dated 05/27/2026

Broker listed Morgan Stanley Smith Barney LLC Broker address shown at 1 New York Plaza, 38th FL

Filing reference date 06/02/2026 Date appearing in securities information header

Key Terms

Restricted stock vest, Form 144, Equity compensation

3 terms

Restricted stock vest regulatory

""Restricted stock vest | Fulgent Genetics, Inc. | 45304 | 02/25/2025""

A restricted stock vest is the moment when shares granted to an employee or executive under conditions (like staying at the company or hitting targets) officially become theirs to keep or sell. Think of it as a timed gift that unlocks only after certain rules are met. Investors watch vesting because it can change who controls shares, create potential selling pressure when large blocks unlock, and reveal how management’s incentives are aligned with company performance.

Form 144 regulatory

"Top of the excerpt identifying the filing type and resale notice"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Equity compensation financial

""Equity compensation for services rendered""

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the FLGT Form 144 disclose about shares to be sold?

The Form 144 reports 45,304 shares classified as "Restricted stock vest" with a vesting date of 02/25/2025. It lists these shares as the securities associated with the resale notice.

Who is the reporting person named in the FLGT Form 144?

The filing names Jian Xie as the reporting person. Contact details include an El Monte, CA address associated with Fulgent Genetics, Inc., as shown in the notice.

Did FLGT report any recent sales in the Form 144?

Yes; the notice shows a sale of 1,201 shares on 05/27/2026. The entry appears under "Securities Sold During The Past 3 Months."

Which broker is listed for the FLGT resale notice?

The broker listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza, 38th Floor, New York, NY, as provided in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 08:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001819718
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FULGENT GENETICS, INC.
SEC File Number	001-37894
Address of Issuer	4399 Santa Anita Ave El Monte CALIFORNIA 91731
Phone	626-350-0537
Name of Person for Whose Account the Securities are To Be Sold	Xie Jian
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th FL New York NY 10004	2146	38382.27	27493435	06/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/25/2025	Resticted stock vest	Fulgent Genetics, Inc.			45304	02/25/2025	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jian Xie C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731	Common Stock	05/27/2026	1201	21137.57

144: Remarks and Signature

Remarks	Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.
Date of Notice	06/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Paul Kim as Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)